Peripheral Arterial Disease Trial, Recruiting NCT06167239 Sponsor: Cairo University Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06167239
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with Guillain-Barré syndrome who have been on a breathing machine (mechanical ventilator) for at least 48 hours and are having difficulty being weaned off it (meaning they have failed at least one attempt to breathe on their own and may need up to three attempts or up to 7 days to successfully come off the ventilator).
  • People aged 18 years or older.
  • People of any sex.
  • People whose ventilator is set to a specific support mode with oxygen levels at or below 50%, low air pressure settings, and a breathing rate below 25 breaths per minute.
  • People who are conscious and aware, with a Glasgow Coma Score of 13 or higher (a measure showing they are alert and oriented).
  • People whose level of alertness and sedation falls within a specific target range on a standard sedation scale (Riker Sedation Agitation Score of 4).
  • People with blood acid-base balance (pH) above 7.25 and blood oxygen levels above 90%.
  • People whose heart and circulation are stable.
  • People with a specific level of breathing muscle strength, able to take breaths independently while on the ventilator.

Who may not be able to join:

  • People with ongoing, life-threatening heart rhythm problems or acute heart failure causing unstable blood pressure or circulation.
  • People experiencing severe difficulty breathing when breathing on their own.
  • People with any ongoing or progressive nerve or muscle disease (other than Guillain-Barré syndrome) that is not stable and could interfere with breathing muscle training.
  • People with a spinal cord injury.
  • People with certain bone or structural problems affecting the chest wall or spine (such as severe curvature of the spine, an unstable chest wall, or spinal implants) that would seriously limit chest movement.
  • People who require heavy sedation or medication to paralyse their breathing muscles.
  • People experiencing dangerously high air pressure in the airways (a condition that can cause lung injury).
  • People with a Body Mass Index (BMI) of 40 or above (a measure of body weight relative to height).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elmasry, Cairo University

Phone: 01005587119

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 May 2023
Est. completion
1 December 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

PH; PaO2; PaCO2; HCO3

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov